Literature DB >> 27984557

Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.

Sherry Deren1, Charles M Cleland, Haekyung Lee, Saurabh Mehandru, Martin Markowitz.   

Abstract

High levels of immune activation are reported for people who inject drugs. Studies of the relationship between injection behaviors and immune activation have yielded mixed results, in part due to lack of control for hepatitis C virus in analyses. This study, of 48 HIV-seronegative people who inject drugs, examines this relationship controlling for hepatitis C virus viremia. Frequency of injection was positively related to markers of immune activation (soluble CD14, %CD8CD38HLADR T cells), as was duration of injection (high-specificity C-reactive protein and D-dimer). Sharing injection equipment was not related to markers studied. Findings suggest that efforts to encourage injection cessation or reduction in frequency can have positive health benefits through reducing immune activation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27984557      PMCID: PMC5388567          DOI: 10.1097/QAI.0000000000001270

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  19 in total

1.  New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users.

Authors:  A Krol; C Flynn; D Vlahov; F Miedema; R A Coutinho; E J van Ameijden
Journal:  Drug Alcohol Depend       Date:  1999-04-01       Impact factor: 4.492

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 3.  The 'immunologic advantage' of HIV-exposed seronegative individuals.

Authors:  Masaaki Miyazawa; Lucia Lopalco; Francesco Mazzotta; Sergio Lo Caputo; Francisco Veas; Mario Clerici
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

Review 4.  Paradoxical changes in innate immunity in aging: recent progress and new directions.

Authors:  Ruth R Montgomery; Albert C Shaw
Journal:  J Leukoc Biol       Date:  2015-07-17       Impact factor: 4.962

Review 5.  The Immune System of HIV-Exposed Uninfected Infants.

Authors:  Bahaa Abu-Raya; Tobias R Kollmann; Arnaud Marchant; Duncan M MacGillivray
Journal:  Front Immunol       Date:  2016-09-28       Impact factor: 7.561

6.  Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Med Microbiol Immunol       Date:  2015-12-22       Impact factor: 3.402

7.  Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.

Authors:  Pedro Batista; Sherry Deren; Angela Banfield; Evelyn Silva; Mario Cruz; Preston Garnes; Charles M Cleland; Saurabh Mehandru; Melissa LaMar; Martin Markowitz
Journal:  AIDS Patient Care STDS       Date:  2016-08       Impact factor: 5.078

8.  Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.

Authors:  G H Mientjes; E J van Ameijden; A J van den Hoek; J Goudsmit; F Miedema; R A Coutinho
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

Review 9.  Immune activation and immune aging in HIV infection.

Authors:  Victor Appay; Anthony D Kelleher
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

10.  Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.

Authors:  Saurabh Mehandru; Sherry Deren; Sung-Yeon Kang; Angela Banfield; Aakash Garg; Donald Garmon; Melissa LaMar; Teresa H Evering; Martin Markowitz
Journal:  J Addict Res Ther       Date:  2015
View more
  5 in total

1.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

Review 2.  Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review.

Authors:  Natalie E Chichetto; Brittanny M Polanka; Kaku A So-Armah; Minhee Sung; Jesse C Stewart; John R Koethe; E Jennifer Edelman; Hilary A Tindle; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.495

3.  DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty.

Authors:  Xinyu Zhang; Ying Hu; Amy C Justice; Boyang Li; Zuoheng Wang; Hongyu Zhao; John H Krystal; Ke Xu
Journal:  Nat Commun       Date:  2017-12-21       Impact factor: 14.919

4.  Employing Respondent Driven Sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learned.

Authors:  Roberto Abadie; Patrick Habecker; Kimberly Gocchi Carrasco; Kathy S Chiou; Samodha Fernando; Sydney J Bennett; Aníbal Valentin-Acevedo; Kirk Dombrowski; John T West; Charles Wood
Journal:  Front Psychiatry       Date:  2022-10-03       Impact factor: 5.435

Review 5.  Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.

Authors:  Christopher C Phelps; Christopher M Walker; Jonathan R Honegger
Journal:  Viruses       Date:  2021-07-13       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.